These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10850404)

  • 1. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.
    Jelliffe R; Bayard D; Milman M; Van Guilder M; Schumitzky A
    Ther Drug Monit; 2000 Jun; 22(3):346-53. PubMed ID: 10850404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapy.
    Jelliffe RW; Bayard D; Schumitzky A; Milman M; Van Guilder M
    Medinfo; 1995; 8 Pt 2():1106-10. PubMed ID: 8591381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapy.
    Jelliffe RW; Bayard D; Schumitzky A; Milman M; Van Guilder M
    Proc Annu Symp Comput Appl Med Care; 1994; ():972. PubMed ID: 7950076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.
    Jelliffe RW; Schumitzky A; Bayard D; Milman M; Van Guilder M; Wang X; Jiang F; Barbaut X; Maire P
    Clin Pharmacokinet; 1998 Jan; 34(1):57-77. PubMed ID: 9474473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
    Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
    Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.
    Hurst AK; Yoshinaga MA; Mitani GH; Foo KA; Jelliffe RW; Harrison EC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1165-71. PubMed ID: 2393277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
    Allegaert K; Flint R; Smits A
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of malignancy on the pharmacokinetics of vancomycin in infants and children.
    Chang D
    Pediatr Infect Dis J; 1995 Aug; 14(8):667-73. PubMed ID: 8532423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
    Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
    Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
    Hughes JH; Keizer RJ
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients.
    Chang D; Liem L; Malogolowkin M
    Pediatr Infect Dis J; 1994 Nov; 13(11):969-74. PubMed ID: 7845750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.
    Jelliffe R; Schumitzky A; Van Guilder M
    Ther Drug Monit; 2000 Jun; 22(3):354-65. PubMed ID: 10850405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.